5 "pancreas cancer" clinical trials found.
-
PANOVA-3: Pivotal randomized open-label study of Tumor Treating Fields (TTFields 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
To test the efficacy and safety of gemcitabine and nab-paclitaxel, with or without TTFields, using the NovoTTF-100L(P) System as a front-line therapy for locally-advanced pancreatic ...
Phase
Interventional
Match Level: Exact
-
A Randomized Phase 2 Study of Losartan and Nivolumab in Combination with FOLFIRINOX and SBRT in Localized Pancreatic Cancer (Stand up to Cancer)
This multi-center, open-label, rando ized Phase II study will evaluate the effectiveness of the addition of the angiotension II type receptor blocker Losartan, or the ...
Phase
Interventional
Match Level: Exact
-
A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas
The purpose of this study is to find out about the safety and efficacy of CPI-613 in the treatment of metastatic pancreatic cancer when used ...
Phase
Interventional
Match Level: Exact
-
A PHASE IIA MULTICENTER OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF BL-8040 AND PEMBROLIZUMAB IN SUBJECTS WITH METASTATIC PANCREATIC CANCER THE COMBAT STUDY
The purpose of this clinical study is to learn if BL-8040 given alone followed by combination with pembrolizumab (KEYTRUDA®) and chemotherapy of Onivyde® + 5-FU/LV ...
Phase
Interventional
Match Level: Exact
-
Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates
The goal of this phase II study is to obtain safety and preliminary efficacy for and estimate the R0 resection rate in patients with ...
Phase
Interventional
Match Level: Exact
